Secondary Logo

Journal Logo

September 10, 2010 - Volume 24 - Issue 14
pp: 2145-2300

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

Tebas, Pablo; Frank, Ian; Lewis, Mark; More

AIDS. 24(14):2187-2192, September 10, 2010.

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy

Cressey, Tim R; Jourdain, Gonzague; Rawangban, Boonsong; More

AIDS. 24(14):2193-2200, September 10, 2010.

Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness

Delaney, Joseph AC; Scherzer, Rebecca; Biggs, Mary L; More

AIDS. 24(14):2201-2209, September 10, 2010.

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

Salmon-Céron, Dominique; Durier, Christine; Desaint, Corinne; More

AIDS. 24(14):2211-2223, September 10, 2010.

A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected children

Zar, Heather J; Workman, Lesley; le Roux, Stanzi M; More

AIDS. 24(14):2225-2232, September 10, 2010.

Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study

Sullivan, Sheena G; Hirsch, Hans H; Franceschi, Silvia; More

AIDS. 24(14):2245-2252, September 10, 2010.

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization

Cohen, Adam L; Harrison, Lee H; Farley, Monica M; More

AIDS. 24(14):2253-2262, September 10, 2010.

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007

Cornell, Morna; Grimsrud, Anna; Fairall, Lara; More

AIDS. 24(14):2263-2270, September 10, 2010.